Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_assertion type Assertion NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_head.
- NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_assertion description "[As far as we know, IGH rearrangements involving t(11;14) and (14;16) are significantly more frequent in PCL than in myeloma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_provenance.
- NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_assertion evidence source_evidence_literature NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_provenance.
- NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_assertion SIO_000772 22075513 NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_provenance.
- NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_assertion wasDerivedFrom befree-2016 NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_provenance.
- NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_assertion wasGeneratedBy ECO_0000203 NP938017.RAe2Vdb6MLEO5AczF6VAG-lLylxE5tmpwmDfIYl9THGvE130_provenance.